SNT - Syntara Limited

[Out Too Soon]

At the risk of talking to myself

Hit a high of $2.70 today

(wish incredible charts would lower their subscription price this chart is delayed by 16 hrs because it's just not worth $18mth to me )

 

[Hedders]

At the risk of talking to myself
View attachment 34034
Hit a high of $2.70 today

(wish incredible charts would lower their subscription price this chart is delayed by 16 hrs because it's just not worth $18mth to me )

It's about time this sleeper woke up a little. PXS's drug Bronchitol looks the goods to me (speaking as a pharmacist now). Fast track status from the FDA is a great sign. Do you think the share price will do much until the 1st quarter of 2010 though?

 

[brickwalls]

According to AC on other forum, PXS were represented at the North American Cystic Fibrosis meeting in Minneapolis 15th - 17th Oct, and its inferred that the buying stemmed from that conference?

 

[Out Too Soon]

Pxs has certainly come to life, here's a link to latest ASX ann
http://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=01004541

I did take profits but I'm back in again today

 

[Out Too Soon]

More good news
FDA Advisory Committee Recommends Approval of Aridol
[URL="http://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=01013769"/URL]

& just to prove the nonsense of the mkt the sp has dropped to $2.35
Maybe someones sell went thru before the ann came out

 

[Hedders]

Well the last couple of days have been good for PXS holders- stock now trading at $2.83, up 33cents in 2 days. Positive phase III trial results attracted buyers...finally. Here's hoping PXS continues to climb. I've watched my shares in this company go sideways for 6 long months- this recent news has broken the monotony if nothing else!

 

[Out Too Soon]

Well the last couple of days have been good for PXS holders- stock now trading at $2.83, up 33cents in 2 days. Positive phase III trial results attracted buyers...finally. Here's hoping PXS continues to climb. I've watched my shares in this company go sideways for 6 long months- this recent news has broken the monotony if nothing else!

"trial results attracted buyers...finally"

What an annoying pasttime share trading is
Got out again before the latest take off purely because it has been frustrating waiting 6 mths for ppl to wake up & take notice. Small profit but out too soon as per usual
Waiting for a retracement that hopefully wont be followed by any 6 mth doldrums

 

[Hedders]

"trial results attracted buyers...finally"

What an annoying pasttime share trading is
Got out again before the latest take off purely because it has been frustrating waiting 6 mths for ppl to wake up & take notice. Small profit but out too soon as per usual
Waiting for a retracement that hopefully wont be followed by any 6 mth doldrums

I nearly followed you on that score- I was just about to sell when PXS took off. Not really sure what it will do now. The stock hasn't traded this high for about 2 years. I think the charts suggest it may climb a little further, but I'm no expert on charts. I guess the cynic in me says the stock will retrace once people forget about the last announcement. It'll probably yo-yo until commercial availability occurs

 

[Linkitme]

Cup and handle breakout on this at 2.75, then there was a retest.
Very big upside from here. First target 4.15

 

[drdave1]

Looking very promising from here and plenty of news drivers due out most notably the US trial results for bronchitol, price action and previous tests suggest a good result.

 

[explod]

Looking very promising from here and plenty of news drivers due out most notably the US trial results for bronchitol, price action and previous tests suggest a good result.

Agree, a good punt this in my view. My wife has bronchiectasis and in trials the drug has literally changed her life. She used to have to tip and drain her lungs daily, none of that since and seemingly her lung capacity has improved out of sight.

Anyway just our experience.

 

[drdave1]

News out today.

Great trial results for bronchitol... Big day tomorrow. This could do anything!
Good luck to all holding

 

[mark_au]

Hi people

any ideas why PXS has dropped massively to 1.965
i thought the news was all good ??? not what i was expecitng at all

 

[explod]

Hi people

any ideas why PXS has dropped massively to 1.965
i thought the news was all good ??? not what i was expecitng at all

No idea, obviously higher expectations were factored in on this. And also just maybe, like Metal Storm, the US will not back something that is not thier idea or that they cannot dominate the rights over.

So much for my "good punt" idea the other day.

Just shows that the old addage of "DO YOUR OWN RESEARCH" is absolutely paramount. Had not been following it for 12 months now, so just shows.

 

[mark_au]

Very strange hey

it all looks like good news, yet something has happened, that causes the market to think not...
im wondering if this is an ideal time to top up, or wether there are other background issues in play... Sigh

No idea, obviously higher expectations were factored in on this. And also just maybe, like Metal Storm, the US will not back something that is not thier idea or that they cannot dominate the rights over.

So much for my "good punt" idea the other day.

Just shows that the old addage of "DO YOUR OWN RESEARCH" is absolutely paramount. Had not been following it for 12 months now, so just shows.

 

[explod]

Cannot understand that there has not been a mention on this stock for some time.

Got myself back in a week ago at .86 and with the affirmation since of the CMPH we will have a big liftoff come Monday.

EU Regulator Recommends Approval of Pharmaxis’s Bronchitol
QBy Makiko Kitamura - Oct 21, 2011 10:48 PM GMT+1100 inShare2More
Business Exchange Buzz up! Digg Print Email Pharmaxis Ltd. (PXS), the Australian developer of an experimental treatment for cystic fibrosis, won a recommendation from a regulatory panel of the European Medicines Agency to market the company’s most-advanced drug.

The Committee for Medicinal Products for Human Use recommended Bronchitol as an add-on therapy for adult cystic fibrosis patients, reversing an earlier decision, the agency said today in a statement.

Bronchitol is an inhaled treatment designed to treat cystic fibrosis, an inherited disorder that causes build-up of sticky mucus in the airways, leading to lung damage and infections that can kill patients before they turn 40. Australian regulators approved the drug in February.

Pharmaxis shares were placed on a trading halt in Australia on Oct. 17 ahead of the recommendation. The stock fell 74 percent on May 25 after the European panel initially voted against approval of Bronchitol.

To contact the reporters on this story: Makiko Kitamura in London at mkitamura1@bloomberg.net

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net

 

[TabJockey]

Great to see the proper decision made. Pharmaxis is a good company with a useful product and will skyrocket Monday.

 

[skc]

Cannot understand that there has not been a mention on this stock for some time.

Got myself back in a week ago at .86 and with the affirmation since of the CMPH we will have a big liftoff come Monday.

I wanted to play it but I didn't know enough about the product to beat the market. And by the time I read up they're already halted.

Very good outcome for PXS and yourself. Will probably double on Monday. It will be interesting to see if they go back to their pre-plunge levels.

 

[explod]

I wanted to play it but I didn't know enough about the product to beat the market. And by the time I read up they're already halted.

Very good outcome for PXS and yourself. Will probably double on Monday. It will be interesting to see if they go back to their pre-plunge levels.

Thanks skc, could well attain that soon. The open should be very interesting indeed.

Latest press will certainly turn some eyes to it when it goes back into trade today.

http://www.theaustralian.com.au/bus...ic-fibrosis-drug/story-fn91v9q3-1226174573303

http://www.smh.com.au/business/pharmaxis-set-for-share-lift-20111023-1mef3.html

 

[skc]

Thanks skc, could well attain that soon. The open should be very interesting indeed.

Latest press will certainly turn some eyes to it when it goes back into trade today.

http://www.theaustralian.com.au/bus...ic-fibrosis-drug/story-fn91v9q3-1226174573303

http://www.smh.com.au/business/pharmaxis-set-for-share-lift-20111023-1mef3.html

The market doesn't actually seem that large... only $750m in Europe.

I can never quite understand how to value these drug developers or how market react to them. Did you ever follow ACL when it got its drug approved? It is now trading well below (>50%) the range pre-announcement!

But given PXS has fallen so much, there has to be a decent bounce up on this news.